Fingerprint
Dive into the research topics of 'Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with Lewis Y-expressing epithelial tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mansoor N. Saleh, Steve Sugarman, James Murray, Joy B. Ostroff, Diane Healey, Dennie Jones, Carol R. Daniel, Donna LeBherz, Hannah Brewer, Nicole Onetto, Albert F. LoBuglio
Research output: Contribution to journal › Article › peer-review